Clinical Massively Parallel Sequencing.
The newest advances in DNA sequencing are based on technologies that perform massively parallel sequencing (MPS). Since 2006, the output from MPS platforms has increased from 20Mb to 7 Tb. First-generation MPS platforms amplify individual DNA molecules to multiple copies and then interrogate the seq...
| Published in: | Clinical Chemistry Vol. 66; no. 1; pp. 77 - 89 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Published: |
Oxford University Press / USA
Jan2020
|
| Online Access: | View this record in EBSCOhost |